Only PUREVAX ® vaccines offer a complete line of nonadjuvanted feline vaccines. PUREVAX vaccines help protect both cats and kittens from dangerous and deadly diseases, and give veterinarians and cat owners the peace of mind of knowing their cats …

PUREVAX ® Feline Rabies vaccines contain a nonadjuvanted lyophilized suspension of a recombinant vectored rabies vaccine plus a sterile water diluent. A canarypox vector has been modified using recombinant technology to produce expression of desired antigens capable of stimulating a protective immune response to rabies.

PUREVAX Recombinant FeLV is the first and only recombinant canarypox-vectored nonadjuvanted feline leukemia virus (FeLV) vaccine. Safe, effective, and pure without adjuvants. Here are a few of the many benefits of PUREVAX ® feline vaccines:

PUREVAX ® is the only fully adjuvant-free feline vaccine range and provides: Optimised safety profile with adjuvant-free protection for all components; Powerful immune response without adjuvant, thanks to its innovative canarypox technology for FeLV and rabies;

2025年3月2日 · INDICATIONS: PUREVAX ® Feline 3 is recommended for the vaccination of healthy cats 6 weeks of age or older for prevention of disease due to feline rhinotracheitis, calici, and panleukopenia viruses. DOSAGE : Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject 1 mL (1 dose) subcutaneously or ...

Purevax ® is the only fully adjuvant‑free feline vaccine range, combining optimal safety with proven efficacy. The Purevax ® range also allows for flexibility by using the core components alone or in combination with non-core components, depending on the individual need of the cat.

PUREVAX FeLV vaccine provided an equivalent degree of protection from persistent antigenemia and integration of proviral DNA as the two killed adjuvanted FeLV vaccines.

PureVax ® Recombinant FeLV contains a non-adjuvanted lyophilized suspension of a recombinant vectored feline leukemia vaccine plus sterile water diluent. A canarypox vector has been modified, using recombinant technology, to produce expression of desired antigens capable of stimulating a protective immune response to feline leukemia.

Purevax RCP Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension.

This medicine is authorised for use in the European Union. vaccine against feline viral rhinotracheitis, feline calicivirosis and feline panleucopenia. Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website. English (EN) (81.94 KB - PDF) English (EN) (81.49 KB - PDF)